Heartflow, a pioneering provider of heart imaging software, has officially filed for an Initial Public Offering (IPO) in the United States, with an ambition to raise $100 million. The company's innovative platform has been instrumental in assessing coronary artery disease in over 400,000 patients, generating annual revenues of $136 million.